For the readers interested in the stock health of Ampio Pharmaceuticals Inc. (AMPE). It is currently valued at $1.75. When the transactions were called off in the previous session, Stock hit the highs of $1.57, after setting-off with the price of $1.54. Company’s stock value dipped to $1.44 during the trading on the day. When the trading was stopped its value was $1.44.Recently in News on September 15, 2021, Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering from Severe Osteoarthritis of the Knee (OAK). – Ampion™ demonstrated statistically significant reduction in pain and improvement in function at 12 weeks in severe OAK patients. You can read further details here
Ampio Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.5900 on 02/12/21, with the lowest value was $1.1850 for the same time period, recorded on 08/04/21.
Ampio Pharmaceuticals Inc. (AMPE) full year performance was 73.75%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Ampio Pharmaceuticals Inc. shares are logging -41.28% during the 52-week period from high price, and 142.79% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.72 and $2.98.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 6889519 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Ampio Pharmaceuticals Inc. (AMPE) recorded performance in the market was -9.43%, having the revenues showcasing -23.81% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 327.17M, as it employees total of 18 workers.
Ampio Pharmaceuticals Inc. (AMPE) in the eye of market guru’s
During the last month, 0 analysts gave the Ampio Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.6560, with a change in the price was noted unch. In a similar fashion, Ampio Pharmaceuticals Inc. posted a movement of unch for the period of last 100 days, recording 1,763,133 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AMPE is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Ampio Pharmaceuticals Inc. (AMPE): Stocks Technical analysis and Trends
Raw Stochastic average of Ampio Pharmaceuticals Inc. in the period of last 50 days is set at 98.37%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 98.04%. In the last 20 days, the company’s Stochastic %K was 63.11% and its Stochastic %D was recorded 54.61%.
If we look into the earlier routines of Ampio Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -9.43%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -20.00%, alongside a boost of 73.75% for the period of the last 12 months. The shares increased approximately by -12.73% in the 7-day charts and went down by -1.37% in the period of the last 30 days. Common stock shares were lifted by -23.81% during last recorded quarter.